Nicholas Hoffman & Company’s Thermo Fisher Scientific TMO Stock Holding History

Nicholas Hoffman & Company’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$425K	Buy	848 +27	+3%	+$13K	0.01%	252
2026 Q1	$404K	Buy	821 +3	+0.4%	+$1.63K	0.01%	249
2025 Q4	$474K	Buy	818 +83	+11%	+$46.9K	0.01%	225
2025 Q3	$356K	Sell	735 -22	-3%	-$10.2K	0.01%	251
2025 Q2	$307K	Buy	757 +235	+45%	+$98.3K	0.01%	250
2025 Q1	$260K	Buy	522 +120	+30%	+$65K	0.01%	259
2024 Q4	$209K	Sell	402 -361	-47%	-$198K	0.01%	272
2024 Q3	$472K	Buy	+763	New	+$452K	0.02%	205
2024 Q2	–	Sell	-366	Closed	-$213K	–	301
2024 Q1	$213K	Buy	+366	New	+$205K	0.01%	276
2023 Q2	–	Sell	-382	Closed	-$220K	–	279
2023 Q1	$220K	Buy	382 +4	+1%	+$2.25K	0.02%	257
2022 Q4	$208K	Buy	+378	New	+$200K	0.02%	250
2022 Q3	–	Sell	-388	Closed	-$211K	–	265
2022 Q2	$211K	Buy	388 +11	+3%	+$6.05K	0.01%	243
2022 Q1	$223K	Buy	+377	New	+$217K	0.01%	260

Other funds holding TMO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Nicholas Hoffman & Company's TMO Position: Q2 2026 in Review

Nicholas Hoffman & Company increased its Thermo Fisher Scientific (TMO) stake by 3.3% in Q2 2026, buying an estimated $13K and bringing the position to 848 shares worth $425K. The position accounts for 0.01% of the portfolio, ranked #252.

Nicholas Hoffman & Company first reported a position in TMO in Q1 2022 and has held it in 13 quarters since. The position peaked at $474K in Q4 2025. 1,619 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

Nicholas Hoffman & Company held 848 shares of Thermo Fisher Scientific worth $425K as of Q2 2026.
Nicholas Hoffman & Company bought 27 Thermo Fisher Scientific shares in Q2 2026, an estimated $13K.
Thermo Fisher Scientific made up 0.01% of Nicholas Hoffman & Company's portfolio in Q2 2026, its #252 holding.
Nicholas Hoffman & Company first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 13 quarters since.
Nicholas Hoffman & Company's Thermo Fisher Scientific position peaked at $474K in Q4 2025.
1,619 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Nicholas Hoffman & Company's 13F filing for Q2 2026, filed 4 Aug 2026.